Jan 21 (Reuters) - Symbio Pharmaceuticals Ltd:
* ‍HAS INITIATED A PHASE 1 STUDY IN JAPAN FOR ORAL TREAKISYM IN PATIENTS WITH PROGRESSIVE SOLID TUMORS​ Source text for Eikon: Further company coverage:
 